LipitorLipitor DrugLipitor
 
What is Cholesterol?
Forms of Cholesterol
Heart Disease
Symptoms of Heart Disease
Heart Disease Prevention
Heart Disease Precaution
What are Statins?
Cholesterol Medications
Lipitor
Lescol
Mevacor
Pravachol
Crestor
Zocor

July 2007
June 2007
May 2007
April 2007
March 2007
February 2007
January 2007
December 2006
November 2006

LipitorCare News » July 07

Pfizer wins Lipitor patent case in Ireland
9 July, 2007

Pfizer Inc. said Tuesday that it won a patent case in Ireland that will prevent generic drugmaker Ranbaxy from launching its own version of Pfizer's blockbuster cholesterol-lowering drug Lipitor.

The ruling, by Dublin's High Court, means Ranbaxy cannot release its generic version until the basic Lipitor patent expires in November 2011.

"Today's decision is yet another affirmation of the strength of the intellectual property behind Lipitor," said Pfizer General Counsel Allan Waxman in a statement.

The ruling is the latest in Pfizer's ongoing battle to keep Lipitor patent-protected. Analysts have been skeptical that the Manhattan-based drugmaker will be able to generate enough sales from Lipitor and other key drugs to offset the billions being lost to generic competition as patents expire.

Earlier this year, an appeals court invalidated Pfizer's patent for high blood pressure drug Norvasc, allowing drug maker Mylan Laboraties Inc. to begin selling a generic version. Generic Norvasc sales cut into about a week of Pfizer's sales for the first quarter. Pfizer's own Norvasc sales dropped 10% to $1.07 billion during the first three months of the year.

In May, Gurgaon, India-based Ranbaxy won an appeal from the Borgarting Court in Oslo, Norway, that overturned a decision on a patent protecting atorvastatin calcium -- Lipitor's active ingredient. Pfizer said in May it plans to appeal that ruling.

Losing patent protection on Lipitor would be a major blow to Pfizer, which earlier this year said it planned to cut 10,000 jobs, or 10% of its workforce. Lipitor generated sales of $12.89 billion in 2006 and in March, the drug was approved for use during heart surgery and to help cut the risk of nonfatal heart attacks, fatal and nonfatal strokes. Pfizer's total revenue last year topped $48 million.

In April, Pfizer and Bristol-Myers inked a partnership to develop and market a drug for stroke prevention and other conditions.

Boob Jobs- Compare Cosmetic Surgery UK will help you find the perfect clinic for breast procedures such as boob jobs or breast reductions.

Source: Newyorkbusiness

safe fat weight loss pills

top drug store guide

hair loss diet pills information

hair lack side effects

drug store place

discount over weight pills

http://www.comparelasereyesurgeryuk.co.uk- Compare Laser Eye Surgery UK is the number 1 comparison service for laser eye correction surgery in the UK. Get the cheapest prices for laser eye treatments.

Buy anabolic steroids- pharma247.net is the place to buy health products such as human hormones and anabolic steroids. For more information, visit http://www.pharma247.net

drug rehab

Herbalife distributor

Personal Trainer- Get qualified male and female personal trainers and fitness trainers in your area from Workout at Home. We use best personal training methods for effective results.

Phrget="blank">Boob Jobs- Compare Cosmetic Surgery UK will help you find the perfect clinic for breast procedures such as boob jobs or breast reductions.

condoms for small penis

Video conference

Traditional Chinese Medicines- TCM Nutra utilizes the wisdom of Traditional Chinese Medicine, herbal medicine and systems biology in the manufacture of proprietary herbal and nutraceutical solutions to modern health care problems.

Drugs Online Canada- Licensed drugs online site from Canada – NorthWestPharmacy.com.

P90X Reviews

Diet Tips-Beauty tips and fitness tips for a youthful look.Look years younger by following right diet and weightloss regimes. Look fantastic in lovely dresses. Exclusive beauty tips

Home | Contact Us | Lipitor Articles
Copyright ©2006-2007 www.lipitorcare.com. All rights reserved